Using a Nu-Med Plus propriety nitric oxide formulation this smaller unit will have the capability to deliver high-purity nitric oxide in single-dose treatments. The design allows for potential expanded use beyond congenital pulmonary hypoplasia and neonatal hypoxia. Additional applications could involve therapeutic need for vasodilation and increased delivery of oxygen to diseased and injured tissue.
*Available commercially upon FDA approval
Stats & Ideal Market
Utilizes proprietary formula for nitric oxide generation
Small unit fits easily in an office environment
Easy to use dose controls